International Journal of Molecular and Cellular Medicine (IJMCM)

A. Scope of the Journal 

The International Journal of Molecular and Cellular Medicine (IJMCM) is a double-blind, peer-reviewed, quarterly publication of the Cellular and Molecular Biology Research Center (CMBRC), Babol University of Medical Sciences, Babol, Iran. The journal publishes cutting-edge research in cellular and molecular biology and medicine, including but not limited to the genetic basis of disease, biomarker discovery, genomics and proteomics, bioinformatics combined with experimental techniques, stem cells and tissue engineering, medical biotechnology, nanomedicine, cellular processes (growth, death, survival), clinical biochemistry, molecular and cellular immunology, and molecular aspects of infectious diseases and cancer.

Article Types Accepted:

IJMCM prioritizes high-impact original research articles and comprehensive reviews. Other article types may be considered under specific conditions:
-  Original Research Articles: Novel findings with rigorous experimental design and broad implications.
-  Reviews: In-depth, critical syntheses of current knowledge in the field. 
-  Mini-Reviews: Focused updates on emerging topics (max 3,000 words). 
-  Systematic Reviews: Evidence-based analyses following PRISMA guidelines. 
-  Case Reports: Accepted only if they demonstrate exceptional novelty or clinical relevance; limited to one per issue. 
-  Short Communications: Brief reports of significant preliminary findings (max 2,000 words). 
-  Letters to the Editor: Concise opinions or responses to published articles (max 1,000 words; start with "Dear Editor" and combine methods/results without detailed comparison). 

B. Manuscript Submission Policies 
 General Requirements:
- Manuscripts must be submitted in English in Word (.doc or .docx) format via the online portal at [www.ijmcmed.org](http://www.ijmcmed.org). 
- Submissions must be original, not previously published, and not under consideration elsewhere. 
-  Preprints: IJMCM does not accept articles previously published as preprints on recognized servers (e.g. bioRxiv).   
-  Artificial Intelligence (AI): AI tools may be used for language editing, data analysis, or responding to reviewer queries, but not for any AI-assisted work; AI tools cannot be listed as authors. Authors must review and take full responsibility for AI-assisted work; AI cannot be listed as an author. 
 Data Sharing:
Authors are required to include a Data Availability Statement in the manuscript, specifying how the data supporting their findings can be accessed (e.g. via public repositories like dbGaP, Sequence Read Archive, or supplementary files). Deposition in recognized repositories is strongly encouraged to promote reproducibility. 

C. Manuscript Format 
The manuscripts must include the following sections in a single file: Title Page, Abstract, Keywords, Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References (in Vancouver Style (http://www.nlm.nih.gov/bsd/uniform_requirements.html)), Tables, and Figures (with legends). A distinct running title (max 50 characters) must be given. 

Title Page: 
-  Title: Concise, specific and informative. 
-  Authors: Provide the full first and last name, affiliation (department, institution, city, country), and current address for each author. Include ORCID iDs, if available. 
-  Corresponding Author: Provide name, address, email, phone and fax (if applicable).

Abstract and Keywords: 
-Abstract: Max 250 words, organized into  Background ,  Methods ,  Results , and  Conclusions . Avoid abbreviations and citations. 
-Keywords: 3–8 terms, based on the Medline MeSH headings (http://www.nlm.nih.gov/mesh/MBrowser.html). 

Text: 
- Use generic drug names, with brand names in parentheses if relevant. 
- Spell out abbreviations/acronyms the first time they are used, followed by the abbreviation in parentheses (e.g. "Polymerase Chain Reaction (PCR)").
- Report measurements in SI units, with traditional units in parentheses (e.g. "1.5 mmol/L (27 mg/dL)"), except for blood pressure (mmHg) and hemoglobin (g/dL). 
- Footnotes are only allowed in tables and figures, not in the main text. 

References:
- Number the references consecutively in the order in which they are cited in the text and use Vancouver Style (http://www.nlm.nih.gov/bsd/uniform_requirements.html). 
- References only cited in tables/figures are numbered in the order in which they are first mentioned in the text. 
- Limit references older than 15 years to classic or seminal works. 
- If there are more than 3 authors, list the first 3, followed by "et al.." 
- Examples: 
  -  Journal : Halpern SD, Ubel PA, Caplan AL, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347(4):284-7.
-  Electronic Journal : Williams JS, Brown SM, Conlin PR. Videos in clinical medicine. Blood-pressure measurement. N Engl J Med. 2009 Jan 29;360(5):e6. doi: 10.1056/NEJMvcm0800157. PMID: 19179309; PMCID: PMC2825670.
  -  Book : Gilstrap LC 3rd, Cunningham FG, VanDorsten JP, editors. Operative obstetrics. 2nd ed. New York: McGraw-Hill; 2002
  -  Book Chapter : Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.
  - Homepage/Web site: eatright.org [Internet]. Chicago: Academy of Nutrition and Dietetics; c2016 [cited 2016 Dec 27]. Available from: https://www.eatright.org/

Tables:
- Create them with the Word table tool, number them consecutively (e.g. Table 1), with a short title above and footnotes below. Insert them at the end of the manuscript after the references. Avoid bulleted lists. 

Figures and Illustrations 
- Number the figures consecutively (e.g. Figure 1), with legends below. Submit them in color (preferred) as high-quality files (e.g. TIFF, JPEG, 300 dpi). Embed the files after the tables or upload them separately. Use 9 pt Arial font for text/labels. IJMCM can resize/crop images for formatting. Do not duplicate data in text, tables and figures.

D. General Considerations 

Peer Review Process 
Manuscripts that meet the submission guidelines will undergo an initial review by the Editor-in-Chief. Qualified manuscripts will be forwarded to at least three expert reviewers. The corresponding author receives all editorial correspondence and is responsible for providing feedback to co-authors and submitting revisions. 

Cover Letter: 

Include a signed, dated cover letter from the corresponding author stating: 
*"The manuscript has been reviewed and approved by all authors, is not under consideration elsewhere, and has not been published in full or part (except in abstract form)."* 
Upload the manuscript as a scanned PDF file via the submission portal.

Conflicts of Interest: 
When submitting, disclose any financial or other interests that may influence the work, including funding sources. 

Ethical Considerations:
-  Human Studies: Confirm informed consent from adult participants (or parents/guardians for minors) and identify the approving institutional review board. 
-  Animal Studies: Ensure compliance with current national laws on animal care and maintenance. 

Copyright:
All authors must sign the copyright transfer agreement, submitted online as a scanned PDF file. Post-acceptance withdrawal is not permitted. The published articles are open access under Creative Commons Attribution (CC BY). 

Corresponding Author’s Responsibilities: 
The corresponding author: 
- Submits copyright and disclosure forms signed by all authors. 
- Shares the reviewers' comments with the co-authors and ensures that the revisions are addressed. 
- Reviews the proofs and returns them within 48 hours. 
- Verifies cover design accuracy if the article is featured. 

Article Processing Charges (APCs) 

Processing fees will be charged for accepted manuscripts: 
 

-  Payment Details : 

• Iranian Authors: Shaba no. IR450100004001084503025236, Melli Bank (Deposit ID: 351084553124910008000000000500).

• Overseas Authors: Account no. 29401911, Swift code: MELIIRTHBBL, Branch code: 9401. 

• Include "IJMCM" and "Babol University of Medical Sciences" on receipts. Submit scanned copies to [intmolcellmedgmail.com] and the portal. 
  

E. Submission Checklist 
Before submission, ensure: 

• The title page includes the title, running title, authors' names, affiliations, ORCID iDs, and corresponding author’s information (email, phone and fax). 

• A manuscript with all required sections and a running title follows. 

• Tables and figures (with legends) are inserted after the references. 

• The cover letter corresponds to the IJMCM format. 

• An iThenticate plagiarism report (<20%) is attached. 

Contact 
 Editor-in-Chief: Prof. Hadi Parsian, Ph.D. 
 Email: infoijmcmed.org
 Website: www.ijmcmed.org